Cart
sales@molnova.com
Pristinamycin IA
CAS No. 3131-03-1
Pristinamycin IA( Mikamycin B | Mikamycin IA )
Catalog No. M26393 CAS No. 3131-03-1
Pristinamycin IA is a substrate for the P-glycoprotein and a cyclo-peptidic macrolactone antibiotic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 231 | In Stock |
|
| 10MG | 375 | In Stock |
|
| 25MG | 627 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePristinamycin IA
-
NoteResearch use only, not for human use.
-
Brief DescriptionPristinamycin IA is a substrate for the P-glycoprotein and a cyclo-peptidic macrolactone antibiotic.
-
DescriptionPristinamycin IA is a substrate for the P-glycoprotein and a cyclo-peptidic macrolactone antibiotic.
-
In Vitro——
-
In Vivo——
-
SynonymsMikamycin B | Mikamycin IA
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3131-03-1
-
Formula Weight866.973
-
Molecular FormulaC45H54N8O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (38.44 mM)
-
SMILESCCC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(NC(=O)C2CC(=O)CCN2C(=O)C(Cc2ccc(cc2)N(C)C)N(C)C(=O)C2CCCN2C1=O)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Li Y, Huang C, Fu W, Zhang H, Lao Y, Zhou H, Tan H, Xu H. Screening of the active fractions from the Coreopsis tinctoria Nutt. Flower on diabetic endothelial protection and determination of the underlying mechanism. J Ethnopharmacol. 2020 May 10;253:112645.
molnova catalog
related products
-
Tyr-ACTH (4-9)
Tyr-ACTH (4-9) is a behaviorally active peptide. Tyr-ACTH (4-9) can be used for research of learned behavior extinction in the rat.
-
Hesperidin
Hesperidin is a flavanone glycoside found abundantly in citrus fruits.
-
Curculigoside B
Curculigoside B shows antioxidative and antiosteoporotic activities, it can decrease area of bone resorption pit, osteoclastic formation and TRAP activity.
